Literature DB >> 1587549

Molecular characterization of the variable regions of a mouse polyreactive IgG2b antibody with rheumatoid factor activity.

A Sequeira1, S Avrameas, E Jouvin-Marche.   

Abstract

The complete nucleotide sequences of heavy and light chains of a mouse polyreactive IgG2b antibody were determined. This antibody, obtained after primary immunization of BALB/c mice with human lymphoblastoid cells, possess anti-HLA-DR and anti-rheumatoid factor activities and reacts with various self and nonself antigens. The VL and VH segments were found to belong to the VK8 and VH7183 families, respectively. The VH segment shared a high percentage of sequence similarity (95%) with previously described germline genes. The VK segment had 98.9% of sequence similarity with a consensus sequence VK8 of antibodies with anti-phosphorylcholine activity. Furthermore, the framework regions 2 and 3 of the VL segment were very similar to the framework regions 2 and 3 of other antibodies known to possess rheumatoid factor activity. We postulate that during immunization, the presence of HLA-DR antigens selects precursors having configurations similar to that of the germline, and induces some somatic mutations that do not significantly affect antibody polyreactivity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587549     DOI: 10.1007/bf00209287

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  50 in total

1.  Fine specificity, idiotypy, and nature of cloned heavy-chain variable region genes of murine monoclonal rheumatoid factor antibodies.

Authors:  A J Manheimer-Lory; M Monestier; B Bellon; F W Alt; C A Bona
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

2.  The evolution of MHC class II genes.

Authors:  F Figueroa; J Klein
Journal:  Immunol Today       Date:  1986-03

3.  HLA-DR-specific monoclonal antibodies cross-react with several self and nonself non-MHC molecules.

Authors:  B Guilbert; M Fellous; S Avrameas
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

4.  Developmentally controlled expression of immunoglobulin VH genes.

Authors:  R M Perlmutter; J F Kearney; S P Chang; L E Hood
Journal:  Science       Date:  1985-03-29       Impact factor: 47.728

5.  B cell repertoire in adult antigen-free and conventional neonatal BALB/c mice. II. Analysis of antigen-binding capacities in relation to VH gene usage.

Authors:  N A Bos; C G Meeuwsen; P Van Wijngaarden; R Benner
Journal:  Eur J Immunol       Date:  1989-10       Impact factor: 5.532

6.  The complete nucleotide sequences of the heavy chain variable regions of six monospecific rheumatoid factors derived from Epstein-Barr virus-transformed B cells isolated from the synovial tissue of patients with rheumatoid arthritis. Further evidence that some autoantibodies are unmutated copies of germ line genes.

Authors:  V Pascual; I Randen; K Thompson; M Sioud; O Forre; J Natvig; J D Capra
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

7.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

8.  Classification of mouse VK groups based on the partial amino acid sequence to the first invariant tryptophan: impact of 14 new sequences from IgG myeloma proteins.

Authors:  M Potter; J B Newell; S Rudikoff; E Haber
Journal:  Mol Immunol       Date:  1982-12       Impact factor: 4.407

9.  The immunoglobulin heavy chain variable region (Igh-V) locus in the mouse. I. One hundred Igh-V genes comprise seven families of homologous genes.

Authors:  P H Brodeur; R Riblet
Journal:  Eur J Immunol       Date:  1984-10       Impact factor: 5.532

10.  Variable region sequences of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors). A structural explanation for the high frequency of IgM anti-IgG B cells.

Authors:  M J Shlomchik; D A Nemazee; V L Sato; J Van Snick; D A Carson; M G Weigert
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.